Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wobenzym Plus for Exercise Induced Muscle Damage
NCT01845558Phase 4Completed
- Sponsor
- Mucos Pharma
- Start
- Feb 2013
- Primary completion
- Sep 2014
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trypsin + bromelain + rutoside in exercise-induced muscle damage (EIMD), sponsored by Mucos Pharma. Started Feb 2013; status: completed.
02
Drugs
trypsin + bromelain + rutoside
03
Conditions
exercise-induced muscle damage (EIMD)
Beyond the preview
Go deeper on NCT01845558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845558.